Back to search

Article

Utility of Cancer Ratio (Serum LDH/Pleural Fluid ADA) and Cancer Plus Ratio (Cancer Ratio/Pleural Fluid Lymphocytic Percentage) in Differentiating Malignant Pleural Effusion and Tubercular Pleural Effusion: A Prospective Observational Study

2025-08-21

Abstract excerpt

<title>Abstract</title> <p>Background Tubercular and malignant pleural effusions are two common causes of exudative effusions in high TB burden countries. Differentiating them accurately is crucial for timely management. Traditional biomarkers often overlap, prompting the need for more specific diagnostic tools. The Cancer Ratio (serum LDH/pleural fluid ADA) and Cancer Plus Ratio (Cancer Ratio/pleural fluid lymph...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f18c3949-02b9-53a5-89ba-94ba02655284
DOI
10.21203/rs.3.rs-7264543/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Utility of Cancer Ratio (Serum LDH/Pleural Fluid ADA) and Cancer Plus Ratio (Cancer Ratio/Pleural Fluid Lymphocytic Percentage) in Differentiating Malignant Pleural Effusion and Tubercular Pleural Effusion: A Prospective Observational StudyDOI 10.21203/rs.3.rs-7264543/v1
Select a neighboring publication to make it the new centre.